Ocera Therapeutics Inc Stock

Stocks

17-11-02	Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Ocera Therapeutics, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
17-10-20	Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®	GL
17-08-23	Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017	GL
17-08-01	Ocera Therapeutics Reports Second Quarter 2017 Financial Results	GL
17-06-01	Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OCERA THERAPEUTICS INC	-.--%	+2.29%	-	-	0
REGENERON PHARMACEUTICALS, INC.	-1.67%	-4.78%	+36.76%	-4.88%	79.3B
CSL LIMITED	-0.44%	+1.45%	-18.40%	-37.28%	59.21B
MODERNA, INC.	-3.35%	-4.92%	+472.81%	+18.32%	55.09B
SAMSUNG BIOLOGICS CO.,LTD.	-6.78%	-4.19%	-3.45%	+28.01%	49.86B
UCB	-0.60%	-2.18%	+8.03%	+159.90%	47.9B
BIOGEN INC.	-1.35%	+0.79%	+65.25%	-18.22%	32.28B
INCYTE CORPORATION	-2.64%	-2.69%	+46.99%	+90.61%	25.21B
INNOVENT BIOLOGICS, INC.	-3.44%	+4.32%	-1.52%	+195.73%	23.87B
SWEDISH ORPHAN BIOVITRUM AB	-3.15%	-0.04%	+59.65%	+113.52%	16.89B
Average	-2.26%	-1.20%	+74.01%	+60.63%	43.29B
Weighted average by Cap.	-2.34%	-2.05%	+83.03%	+40.44%

Employees

Sector